John Buchanan
About John Buchanan
John Buchanan serves as the Associate Director of Intellectual Property at Deciphera Pharmaceuticals, bringing extensive experience in patent law and medicinal chemistry. His background includes roles at several prominent law firms and a strong academic foundation in chemistry and organic chemistry.
Current Role at Deciphera Pharmaceuticals
John Buchanan serves as the Associate Director of Intellectual Property at Deciphera Pharmaceuticals. He has held this position since 2023, contributing to the company's intellectual property management strategies. His role involves overseeing property-based design initiatives and ensuring the protection of the company's innovations in the pharmaceutical sector.
Previous Experience in Intellectual Property Law
Prior to his current role, John Buchanan worked as an Associate Patent Attorney at Burns & Levinson LLP from 2021 to 2023. He also served in a similar capacity at Mintz from 2017 to 2019. His experience in patent law has equipped him with a strong foundation in intellectual property management, particularly in the life sciences sector.
Educational Background
John Buchanan obtained his Juris Doctor (J.D.) degree from Boston College Law School, where he studied from 2014 to 2017. He also holds a Doctor of Philosophy (Ph.D.) in Organic Chemistry from the University of Wisconsin-Madison, which he completed from 1986 to 1992. Additionally, he earned a Bachelor of Science (B.S.) in Chemistry and Mathematics from Hope College between 1982 and 1986.
Expertise in Medicinal Chemistry
John Buchanan possesses expertise in medicinal chemistry and structure-based design, with a focus on oncology, inflammation, and neuroscience. His specialized skills include organic synthesis, heterocyclic chemistry, and parallel synthesis, which are essential in the development of new pharmaceutical compounds.
Career in Scientific Research
Before transitioning to intellectual property law, John Buchanan had a significant career in scientific research. He worked as a Senior Scientist at Kinetix/Amgen Inc. from 2000 to 2011. His extensive experience in the pharmaceutical industry has informed his approach to intellectual property and patent law.